查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1363304

术中神经监测市场规模、份额和趋势分析报告：2023-2030 年按类型、地区和细分市场分類的趋势

Intraoperative Neuromonitoring Market Size, Share & Trends Analysis Report By Type (Insourced, Outsourced), By Region (North America, Europe, Asia Pacific, Latin America, MEA), And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 110 Pages | 商品交期: 2-10个工作天内

价格

术中神经监测市场成长与趋势：

Grand View Research, Inc.最新报告显示，预计2030年全球术中神经监测市场规模将达46.5亿美元，2023年至2030年年复合成长率为4.9%。

这一增长归因于技术进步、设备安全意识增强以及老年人口不断增长。 COVID-19 的爆发预计将对市场产生双重影响。 2020 年 3 月，美国外科医生学会 (ACS) 发表声明，提案减少、推迟或取消择期手术，因为美国的COVID-19 病例迅速增加，并称这将阻碍增长。

此外，Elsevier杂誌（国际出血性中风协会；2021年1月）发表的一项研究发现，高达36%的住院COVID-19患者可能出现神经系统症状，导致缺血性和出血性梗塞。与此相关的病例有多个。此外，2021 年 6 月发表在 Neurology Online Journal 上的另一项最新研究表明，COVID-19 病毒可能与新的神经系统疾病的发展有关。新疾病的增加增加了院内死亡风险并降低了出院率。这些特征预计将在预测期内带来良好的成长。

此外，由于神经外科手术的数量和负担能力不断增加，以及对手术期间病人安全的日益关注，预计该市场将会成长。术中神经监测（IONM）已被医院广泛应用于手术中，因为它可以减少再次手术的次数以及术后併发症和后遗症的发生。

术中神经监测市场报告亮点

  • 按类型划分，内包细分市场所占份额最大，到 2022 年将达到 54.4%。这可能是由于患者和医生对 IONM 益处的认识不断提高，这导致医院在复杂的手术中使用 IONM。这是IONM在该市场占据主导地位的主要原因。
  • 按地区划分，北美地区占比最大，2022年为49.3%。有利的报销方案和技术进步是这一优势的原因。
  • 亚太地区预计在预测期内复合年复合成长率最快，达到 5.46%。这种增长可能是要素老年人口的增加、手术数量的增加以及医疗保健支出的增加。

目录

第1章调查方法与范围

第2章执行摘要

第3章中神经监测市场变数、趋势与范围

  • 市场体系预测
    • 母市场预测
    • 相关/附随市场预测
  • 普及和成长预测图
  • 市场动态
    • 市场促进因素分析
    • 市场抑制因素分析
  • 术中神经监测市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第4章术中神经监测市场：按类型估计和趋势分析

  • 术中神经监测市场：重点
  • 术中神经监测市场：2022 年和 2030 年类型变动与市场占有率分析
  • 内源
  • 外包

第5章中神经监测市场：区域估计与趋势分析

  • 区域预测
  • 按地区分類的术中神经监测市场：重点
  • 北美洲
    • 2018-2030 年市场估计与预测
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 瑞典
    • 挪威
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 泰国
    • 韩国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第6章竞争形势

  • 主要市场参与企业的最新趋势和影响分析
  • 市场参与企业分类
    • Natus Medical Incorporated
    • Accurate Monitoring
    • Neuromonitoring Technologies
    • Medtronic
    • NuVasive, Inc.
    • SpecialtyCare
Product Code: GVR-1-68038-767-4

Intraoperative Neuromonitoring Market Growth & Trends:

The global intraoperative neuromonitoring market size is expected to reach USD 4.65 billion by 2030, registering a CAGR of 4.9% from 2023 to 2030, according to a new report by Grand View Research, Inc.. This growth can be attributed to technological advancements, increasing awareness regarding the safety of the devices, and the growing geriatric population. The COVID-19 outbreak is expected to have a dual impact on the market. In March 2020, the American College of Surgeons (ACS) published a proposal to reduce, postpone, or cancel elective surgeries as COVID-19 cases grew quickly in the U.S., which is expected to hamper growth.

Moreover, according to a research study published in Elsevier journal (International Hemorrhagic Stroke Association; Jan 2021), up to 36% of hospitalized COVID-19 patients might exhibit neurological symptoms, and there were several cases related to ischemic & hemorrhagic infarction. In addition, another recent research study published in Neurology Online Journal in June 2021 proposed that the COVID-19 virus might be responsible for patients acquiring novel neurological diseases. Owing to the growth of new diseases, there is a higher risk of in-hospital mortality and a low discharge rate. These characteristics are expected to result in lucrative growth over the forecast period.

Furthermore, the market is expected to witness growth due to the increasing number & affordability of neurosurgeries and the growing emphasis on patient safety in surgeries. Hospitals are adopting Intraoperative Neuromonitoring (IONM) in a wide spectrum of surgeries, as it reduces the number of revision surgeries and results in fewer postoperative complications & cases of permanent impairment.

Intraoperative Neuromonitoring Market Report Highlights:

  • By type, the insourced segment accounted for the largest share of 54.4% in 2022. This can be attributed to growing awareness among physicians as well as patients about the benefits of IONM, which results in the hospitals utilizing IONM during complex procedures. This is a key reason for the dominance of insourced IONM in the market
  • By region, North America accounted for the largest share of 49.3% in 2022. Favorable reimbursement scenarios along with technological advancements can be attributed to this dominance
  • Asia Pacific is expected to witness the fastest CAGR of 5.46% over the forecast period. The growing geriatric population, increasing number of surgeries, and rising expenditure on healthcare can be attributed to this growth

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Type
    • 1.1.2. Regional scope
    • 1.1.3. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Intraoperative Neuromonitoring Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Intraoperative Neuromonitoring Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's Five Forces
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Intraoperative Neuromonitoring Market: Type Estimates & Trend Analysis

  • 4.1. Intraoperative Neuromonitoring Market: Key Takeaways
  • 4.2. Intraoperative Neuromonitoring Market: Type Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Insourced
    • 4.3.1. Insourced market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Outsourced
    • 4.4.1. Outsourced market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Intraoperative Neuromonitoring Market: Regional Estimates & Trend Analysis

  • 5.1. Regional Outlook
  • 5.2. Intraoperative Neuromonitoring Market by Region: Key Takeaways
  • 5.3. North America
    • 5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.3.2. U.S.
      • 5.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.3.3. Canada
      • 5.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.4. Europe
    • 5.4.1. UK
      • 5.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.2. Germany
      • 5.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.3. France
      • 5.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.4. Italy
      • 5.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.5. Spain
      • 5.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.6. Sweden
      • 5.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.7. Norway
      • 5.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.8. Denmark
      • 5.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.5. Asia Pacific
    • 5.5.1. Japan
      • 5.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.2. China
      • 5.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.3. India
      • 5.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.4. Australia
      • 5.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.5. Thailand
      • 5.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.6. South Korea
      • 5.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.6. Latin America
    • 5.6.1. Brazil
      • 5.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.6.2. Mexico
      • 5.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.6.3. Argentina
      • 5.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.7. MEA
    • 5.7.1. South Africa
      • 5.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.7.2. Saudi Arabia
      • 5.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.7.3. UAE
      • 5.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.7.4. Kuwait
      • 5.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 6.2. Market Participant Categorization
    • 6.2.1. Natus Medical Incorporated
      • 6.2.1.1. Company overview
      • 6.2.1.2. Financial performance
      • 6.2.1.3. Product benchmarking
      • 6.2.1.4. Strategic initiatives
    • 6.2.2. Accurate Monitoring
      • 6.2.2.1. Company overview
      • 6.2.2.2. Financial performance
      • 6.2.2.3. Product benchmarking
      • 6.2.2.4. Strategic initiatives
    • 6.2.3. Neuromonitoring Technologies
      • 6.2.3.1. Company overview
      • 6.2.3.2. Financial performance
      • 6.2.3.3. Product benchmarking
      • 6.2.3.4. Strategic initiatives
    • 6.2.4. Medtronic
      • 6.2.4.1. Company overview
      • 6.2.4.2. Financial performance
      • 6.2.4.3. Product benchmarking
      • 6.2.4.4. Strategic initiatives
    • 6.2.5. NuVasive, Inc.
      • 6.2.5.1. Company overview
      • 6.2.5.2. Financial performance
      • 6.2.5.3. Product benchmarking
      • 6.2.5.4. Strategic initiatives
    • 6.2.6. SpecialtyCare
      • 6.2.6.1. Company overview
      • 6.2.6.2. Financial performance
      • 6.2.6.3. Product benchmarking
      • 6.2.6.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 North America intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
  • Table 3 North America intraoperative neuromonitoring market, by region, 2018 - 2030 (USD Million)
  • Table 4 U.S. intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
  • Table 5 Canada intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
  • Table 6 Europe intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
  • Table 7 Europe intraoperative neuromonitoring market, by region, 2018 - 2030 (USD Million)
  • Table 8 Germany intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
  • Table 9 UK intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
  • Table 10 France intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
  • Table 11 Italy intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
  • Table 12 Spain intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
  • Table 13 Sweden intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
  • Table 14 Norway intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
  • Table 15 Denmark intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
  • Table 16 Asia Pacific intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
  • Table 17 Asia Pacific intraoperative neuromonitoring market, by region, 2018 - 2030 (USD Million)
  • Table 18 Japan intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
  • Table 19 China intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
  • Table 20 India intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
  • Table 21 Australia intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
  • Table 22 Thailand intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
  • Table 23 South Korea intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
  • Table 24 Latin America intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
  • Table 25 Latin America intraoperative neuromonitoring market, by region, 2018 - 2030 (USD Million)
  • Table 26 Brazil intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
  • Table 27 Mexico intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
  • Table 28 Argentina intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
  • Table 29 Middle East and Africa intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
  • Table 30 Middle East and Africa intraoperative neuromonitoring market, by region, 2018 - 2030 (USD Million)
  • Table 31 South Africa intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
  • Table 32 Saudi Arabia intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
  • Table 33 UAE intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
  • Table 34 Kuwait intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 QFD modeling for market share assessment
  • Fig. 6 Market formulation & validation
  • Fig. 7 Intraoperative neuromonitoring: Market outlook
  • Fig. 8 Intraoperative neuromonitoring: Competitive insights
  • Fig. 9 Parent market outlook
  • Fig. 10 Related/ancillary market outlook
  • Fig. 11 Penetration and growth prospect mapping
  • Fig. 12 Industry value chain analysis
  • Fig. 13 Intraoperative neuromonitoring market driver impact
  • Fig. 14 Intraoperative neuromonitoring market restraint impact
  • Fig. 15 Intraoperative neuromonitoring market strategic initiatives analysis
  • Fig. 16 Intraoperative neuromonitoring market: Type movement analysis
  • Fig. 17 Intraoperative neuromonitoring market: Type outlook and key takeaways
  • Fig. 18 Insourced market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 19 Outsourced market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Global intraoperative neuromonitoring market: Regional movement analysis
  • Fig. 21 Global intraoperative neuromonitoring market: Regional outlook and key takeaways
  • Fig. 22 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)